Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

BACKGROUND: Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakizaki, Ryota, Minami, Yoshiyasu, Katamine, Masahiro, Katsura, Aritomo, Muramatsu, Yusuke, Hashimoto, Takuya, Meguro, Kentaro, Shimohama, Takao, Ako, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531093/
https://www.ncbi.nlm.nih.gov/pubmed/33004019
http://dx.doi.org/10.1186/s12933-020-01145-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531093/
https://www.ncbi.nlm.nih.gov/pubmed/33004019
http://dx.doi.org/10.1186/s12933-020-01145-x

Ejemplares similares